Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS
Exhibitor: ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION
Date: 2026-07-13
Booth No.: L717
The Italian Trade Agency (ITA) proudly enriches the Italian Pavilion at Bio-Asia Taiwan 2026 by showcasing the very best of national biotechnology, pharmaceutical excellence, and advanced life sciences. Operating as the core institutional driver for internationalization, ITA is deeply committed to expanding the global footprint of Italian enterprises, facilitating high-level industrial cooperation, and fostering strategic commercial relationships across the globe. By bringing a curated delegation of pioneering companies to Taipei, the agency highlights Italy's prominent role in the evolution of modern healthcare, where rigorous scientific research meets sustainable industrial development.
Through the active and strategic support of the ITA platform, this institutional presence serves as a vital bridge between elite European innovation and the rapidly growing Asia-Pacific market. The agency's primary mission remains to establish long-term bilateral partnerships, accelerate international trade, and support companies that embody the highest standards of technological evolution. By creating solid networks between institutions, researchers, and industrial partners, ITA facilitates the global exchange of scientific know-how and enhances the competitiveness of the Italian bio-pharma sector on the world stage.
This collaborative framework ensures that revolutionary, medical-grade healthcare solutions are successfully introduced to international markets, offering innovative alternatives for modern therapeutic needs. By emphasizing quality, safety, and strict regulatory compliance, ITA's curation guarantees that every showcased reality brings exceptional value to global healthcare professionals. Ultimately, this synergy serves to build mutual trust, drive economic growth, and bring ultimate peace of mind directly to Asian consumers and global partners alike.
Deakos
Deakos originates from Italy and is founded on the principles of natural botanical pharmacology supported by modern scientific research. With more than 20 years of expertise, the company has developed a range of exclusive formulations based on natural herbal ingredients to provide highly effective protection. By combining natural science with the power of plants, Deakos is dedicated to advancing the concept of “medical protection through natural botanical extracts,” successfully bridging the gap between natural solutions and clinical efficacy.
Since its establishment in 2002, Deakos has maintained close collaborations with leading healthcare institutions and has been officially recommended by Italy’s local health authorities (ASL). Its products have also been used clinically by ASL Roma 1, one of Italy’s largest public healthcare organizations, for over 20 years. In May this year, Deakos was further recognized in Taiwan through the Medical Expert Quality Evaluation Certification Program jointly organized by the National Health Research Institutes (NHRI) and the International Family Health Protection Association, receiving the Bronze Award after evaluation by more than ten specialists from different medical disciplines.
Leveraging its strong Italian R&D expertise, Deakos has applied its D-Mannose know-how not only to urinary tract health products for both men and women, but also to skin and wound care solutions designed for sensitive and at-risk populations, including individuals with atopic-prone skin, diabetes, and cancer. Today, Deakos products are available in more than 20,000 pharmacies and healthcare outlets across Europe, including Italy, Germany, France, and Spain.
Deakos serves users of all ages and is widely trusted for urinary and skin care applications among special-needs populations. For this reason, the company’s founder places great emphasis on ingredient purity and minimizing unnecessary chemical additives. The philosophy is simple: the purer the ingredients, the greater the body’s well-being. From intimate care to comprehensive skin protection, Deakos remains committed to manufacturing products according to medical-grade standards, ensuring peace of mind for every user.
More Exhibitor's Press Release
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08
- Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic LONZA / 2026-07-08
- Lonza Expands HPAPI Capacity in Visp,Further Supporting its Position in Payload-Linker Manufacturing LONZA / 2026-07-08
- 20 Years of MDG: From CRO to CIO MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- Accelerating Cell, Gene and Regenerative Medicine Development with an Integrated Platform MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- MDG Connects Japan's Leading Nonclinical Research Resources to Accelerate Advanced Therapies MEDGAEA LIFE SCIENCES LTD. / 2026-07-07
- NYCU Pavilion at BIO Asia–Taiwan 2026 NATIONAL YANG MING CHIAO TUNG UNIVERSITY / 2026-07-07
- US-Based, Globally Connected: Building a Global Platform for Precision Cancer Testing EG BIOMED US INC. / 2026-07-07
- Advancing First Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 Study of Antroquinonol GOLDEN BIOTECHNOLOGY CORP. / 2026-07-06
- How to Run Clinical Trials Efficiently EFFICIENT PHARMA MANAGEMENT CORP. / 2026-07-03
- Noah AI Announces AI Analyst — Designed for Biopharma Investment and Business Decision-Making SHANGHAI NOAH AI TECHNOLOGY CO., LTD. / 2026-07-01